UBS Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

UBS Group’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-150	Closed	-$26K	–	8359
2018 Q3	$26K	Buy	+150	New	+$27.5K	﹤0.01%	6641

Other funds holding CSCI

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group's CSCI Position: Q3 2025 in Review

UBS Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 2,369 shares — an estimated $8.05K sold.

UBS Group first reported a position in CSCI in Q4 2014 and held it in 24 quarters. The position peaked at $25K in Q4 2014. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.

UBS Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
UBS Group sold 2,369 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $8.05K.
UBS Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2014 and held it in 24 quarters.
UBS Group's COSCIENS Biopharma Inc. Common Stock position peaked at $25K in Q4 2014.
2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.